PARSIPPANY, NJ, Oct. 20, 2022 (GLOBE NEWSWIRE) Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG), a fully integrated commercial.
The cooperative venture which aims to improve access to scholarly research materials includes more than 40 academic libraries in 10 countries around the Pacific Rim.